In silico chemical library screening and experimental validation of novel compounds with potential varroacide activities.

The mite Varroa destructor is an ectoparasite and has been identified as a major cause of worldwide honey bee colony losses. The use of yearly treatments for the control of varroosis is the most common answer to prevent collapses of honey bee colonies due to the mite. However, the number of effective acaricides is small and the mite tends to become resistant to these few active molecules. In this study, we have been looking for a new original varroacide treatment inhibiting selectively Varroa destructor AChE (vdAChE) with respect to Apis mellifera AChE (amAChE). To do this an original drug design methodology was used applying virtual screening of the CERMN chemolibrary, starting from a vdAChE homology sequence model. By combining the in silico screening with in vitro experiments, two promising compounds were found. In vitro tests of AChE inhibition for both species have confirmed good selectivity toward the mite vdAChE. Moreover, an in vivo protocol was performed and highlighted a varroacide activity without acute consequences on honey bee survival. The two compounds discovered have the potential to become new drug leads for the development of new treatments against the mite varroa. The method described here clearly shows the potential of a drug-design approach to develop new solutions to safeguard honey bee health.

Effect of oral exposure to the acaricide pirimicarb, a new varroacide candidate, on Apis mellifera feeding rate.

BACKGROUND: The ectoparasitic honey bee mite Varroa destructor is a main cause of the gradual decline in honey bees Apis mellifera. Beekeepers currently utilize a wide range of different synthetic acaricides, organic acids and essential oils to keep mite populations under control. Previous work has indicated that pirimicarb may be a new varroacide candidate. The aim of this study was to observe chronic effects on feeding activity in worker honey bees after oral exposure to 1.05 mm pirimicarb. The long-term effects of 24 h exposure to pirimicarb were also tested. RESULTS: After three successive trials, no mortality could be detected at the tested concentration, although oral exposure to pirimicarb had a significant effect on honey bees feeding behavior. Pirimicarb added to a sucrose solution led to a rapid decrease in food intake. These tendencies may be reversed when the pesticide is removed. However, recovery seemed to be trial dependent. CONCLUSION: This study highlights seasonal variation in honey bee susceptibility, which should be considered in toxicology studies. © 2018 Society of Chemical Industry.